# rivamed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rivamed

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.rivamed.cn
- Latest round: Series B (Jan 21, 2021)
- Investors on record: 4

## About

Rivamed specializes in advanced smart medical solutions tailored for hospital environments, enhancing operational efficiency through innovative technology.Founded in 2014, Rivamed is based in Beijing, China, and focuses on developing smart medical management systems. The company has successfully executed 2 deals, with its most recent funding round occurring on January 21, 2021. The founder's information is currently unavailable.Rivamed specializes in the development and provision of advanced smart medical solutions specifically designed for hospital environments. Their core product offerings include a range of intelligent medical management systems such as smart medication cabinets, intelligent narcotic drug management carts, and RFID-enabled high-value consumable management systems. These products leverage Internet of Things (IoT) technology to enhance the efficiency and accuracy of clinical workflows, addressing critical needs such as resource allocation in operating rooms, supply chain management, and daily nursing operations. The company targets a diversified client base, predominantly consisting of hospitals and healthcare institutions in various geographical markets, including major urban centers across Asia and Europe, aiming to redefine hospital operational processes and improve patient care through innovative, technology-driven solutions.Rivamed’s revenue model primarily involves B2B transactions, where hospitals and healthcare providers procure their smart medical management systems to enhance operational efficiency. The business structure centers around the direct sale of their products, potentially supplemented by service agreements for ongoing support and technology updates. While specific pricing plans for their flagship products, such as the smart high-value consumable cabinet and the intelligent medication management cabinet, are not disclosed, it is understood that pricing structures may include initial purchase costs followed by potential subscription-based services for software support and upgrades. This transactional approach ensures that hospitals benefit from continuous improvements in their operational capabilities while also managing costs associated with clinical care delivery.In January 2021, Rivamed raised Series B funding led by new investor SDIC Venture Capital, with participation from China Creation Ventures, Delta Capital, and returning investor In Capital. The financial terms of the deal were not disclosed. Moving forward, Rivamed plans to develop and launch new products aimed at enhancing their existing offerings. They are also looking to expand into new markets, specifically targeting further penetration in Asia and Europe by the end of 2023. The funds raised will be utilized to support these product development initiatives and market expansion strategies.

## Funding rounds

- Series B, Jan 21, 2021 — Delta Capital, In Capital, Cyber Creation Ventures (CCV), SDIC Venture Capital
- Series A, Dec 12, 2017 — In Capital

## Investors

- In Capital — Series A, Series B
- Delta Capital (https://capitalatlas.ai/funds/delta-capital) — Series B
- Cyber Creation Ventures (CCV) (https://capitalatlas.ai/funds/cyber-creation-ventures-ccv) — Series B
- SDIC Venture Capital (https://capitalatlas.ai/funds/sdic-venture-capital) — Series B